PROCEPT (PRCT) EVP & CTO Barry Templin Sells 358 Shares

What Happened

Barry L. Templin, Executive Vice President and Chief Technology Officer of PROCEPT BioRobotics (PRCT), sold 358 shares on June 8, 2026 at $28.48 per share, for proceeds of $10,195. The transaction is reported as a sale (code S) and, per the filing footnote, was executed as a sell-to-cover to satisfy tax withholding tied to RSUs that vested June 5, 2026.

Key Details

• Transaction date and price: June 8, 2026 — 358 shares sold at $28.48 each (total $10,195).
• Transaction type: Sale (open market or private sale), reported as code S; sale made to cover taxes (footnote F1).
• Shares owned after transaction: Not stated in the provided excerpt; the filing notes holding activity including 860 shares acquired May 14, 2026 under the 2021 Employee Stock Purchase Plan (footnote F2).
• Footnotes: F1 — sale was sell-to-cover for RSU tax withholding from RSU vesting on June 5, 2026. F2 — includes 860 shares purchased May 14, 2026 via ESPP.
• Filing timeliness: Report filed June 10, 2026 for a June 8 transaction — appears to be timely (within the typical 2-business-day Form 4 window).

Context

Sell-to-cover transactions are a common, routine way for insiders to satisfy tax obligations when restricted stock units vest and generally do not by themselves signal a change in the insider’s view of the company. The filing does not indicate a discretionary open-market sale tied to trading plans (e.g., 10b5-1) nor that the reporting person is a 10% owner.